Drugs and Devices

FDA seeks advice on metal-on-metal hip replacements

On March 29, the U.S. Food and Drug Administration (FDA) announced that a two-day expert advisory panel meeting on metal-on-metal hip replacement systems will take place June 27-28. The FDA wants to know more about the risk and benefits of the systems, their use, and the management of patients. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares